Four new cadmium(II) complexes [Cd 2 (bz) 4 (H 2 O) 4 (μ 2 -hmt)]·Hbz·H 2 O ( 1 ), [Cd 3 (bz) 6 (H 2 O) 6 (μ 2 -hmt) 2 ]·6H 2 O ( 2 ), [Cd(pa) 2 (H 2 O)(μ 2 -hmt)] n ( 3 ), and {[Cd 3 (ac) 6 (H 2 O) 3 (μ 3 -hmt) 2 ]·6H 2 O} n ( 4 ) with hexamine (hmt) and monocarboxylate ions, benzoate (bz), phenylacetate (pa), or acetate (ac) have been synthesized and characterized structurally. Structure determinations reveal that 1 is dinuclear, 2 is trinuclear, 3 is a one-dimensional (1D) infinite chain, and 4 is a two-dimensional (2D) polymer with fused hexagonal rings consisting of Cd II and hmt. All the Cd II atoms in the four complexes (except one Cd II in 2 ) possess seven-coordinate pentagonal bipyramidal geometry with the various chelating bidentate carboxylate groups in equatorial sites. One of the Cd II ions in 2, a complex that contains two monodentate carboxylates is in a distorted octahedral environment. The bridging mode of hmt is μ 2 - in complexes 1 − 3 but is μ 3 - in complex 4 . In all complexes, there are significant numbers of H-bonds, C−H/π, and π−π interactions which play crucial roles in forming the supramolecular networks. The importance of the noncovalent interactions in terms of energies and geometries has been analyzed using high level ab initio calculations. The effect of the cadmium coordinated to hmt on the energetic features of the C−H/π interaction is analyzed. Finally, the interplay between C−H/π and π−π interactions observed in the crystal structure of 3 is also studied.
No takes yet. Share an insight, caveat, or question.
Hazra et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: